PURE BIOSCIENCE IN COM NPV (PURE)

1.19
0.20 19.60
OTC
Prev Close 0.99
Open 1.04
Day Low/High 1.04 / 1.28
52 Wk Low/High 0.65 / 1.55
Volume 684.43K
Exchange OTC
Shares Outstanding 64.65B
Market Cap 64.32M
Div & Yield N.A. (N.A)

Latest News

Four Leading Produce Processors Now Conducting Use Trials With FDA Approved PURE Control® To Prevent Foodborne Illness

Four Leading Produce Processors Now Conducting Use Trials With FDA Approved PURE Control® To Prevent Foodborne Illness

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today provided an update on the commercialization efforts of FDA approved PURE Control® as a food safety...

Two National Restaurant Chains Adopt PURE® Hard Surface Disinfectant As A Food Safety Solution

Two National Restaurant Chains Adopt PURE® Hard Surface Disinfectant As A Food Safety Solution

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today announced that it had shipped orders for SDC-based PURE® Hard Surface disinfectant to two national...

PURE Bioscience To Present At Rodman & Renshaw's 2016 Annual Global Investment Conference On September 13th

PURE Bioscience To Present At Rodman & Renshaw's 2016 Annual Global Investment Conference On September 13th

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today the Company will present at Rodman & Renshaw's 2016 Annual Global Investment Conference on...

PureCircle Announces $100 Million Investment In Agronomy Program

PureCircle Announces $100 Million Investment In Agronomy Program

Expands Stevia Farming To New Regions Allowing For 10,000 Hectare Pipeline

PURE Bioscience Receives USDA No Objection Letter For Use Of SDC-Based PURE Control® Antimicrobial In Poultry Processing For Pre-OLR And Post Chill Applications

PURE Bioscience Receives USDA No Objection Letter For Use Of SDC-Based PURE Control® Antimicrobial In Poultry Processing For Pre-OLR And Post Chill Applications

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today announced that it received a "No Objection Letter" from the USDA's Food Safety and Inspection Service...

PURE® Hard Surface Disinfectant - Expands Its Reach In Restaurant Industry

PURE® Hard Surface Disinfectant - Expands Its Reach In Restaurant Industry

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today announced that it has initiated operational testing of PURE® Hard Surface disinfectant with a...

PURE Bioscience Reports 2016 Fiscal Third Quarter And Nine-Month Financial Results

PURE Bioscience Reports 2016 Fiscal Third Quarter And Nine-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal third quarter and nine-month periods ended April 30, 2016.

OTCQX And OTCQB Companies To Present At 2016 Marcum MicroCap Conference

OTCQX And OTCQB Companies To Present At 2016 Marcum MicroCap Conference

OTC Markets Group, President and CEO R. Cromwell Coulson, will speak on panel "Understanding Reg A+ and the 'Mini IPO'"

PURE Bioscience Raises $1.27 Million From Warrant Exercise

PURE Bioscience Raises $1.27 Million From Warrant Exercise

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today that the Company raised $1.

PURE Bioscience Sets Q3 Results Conference Call To Update Progress Of FDA Approved PURE Control® Antimicrobial And The Company's Food Safety Solutions Strategy

PURE Bioscience Sets Q3 Results Conference Call To Update Progress Of FDA Approved PURE Control® Antimicrobial And The Company's Food Safety Solutions Strategy

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today that on June 9, 2016 the Company will file its Form 10-Q shortly after the close of the market...

PURE Bioscience To Present At The 2016 Marcum MicroCap Conference On June 2nd

PURE Bioscience To Present At The 2016 Marcum MicroCap Conference On June 2nd

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today the Company will present at the 2016 Marcum MicroCap Conference at 11:30am EDT on Thursday,...

PURE Bioscience To Present At The Joseph Gunnar

PURE Bioscience To Present At The Joseph Gunnar "Pioneers 2016" Conference On May 5th

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today the Company will present at the Joseph Gunnar "Pioneers 2016" Conference on May 5, 2016 at the...

PURE Bioscience Receives USDA Permission Letter To Begin In-Plant Poultry Processing Trial Using SDC-Based PURE Control® Antimicrobial

PURE Bioscience Receives USDA Permission Letter To Begin In-Plant Poultry Processing Trial Using SDC-Based PURE Control® Antimicrobial

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today announced the Company has received a permission letter from the USDA's Food Safety and Inspection Service...

PURE Bioscience Reports 2016 Fiscal Second Quarter And Six-Month Financial Results

PURE Bioscience Reports 2016 Fiscal Second Quarter And Six-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today reported financial results for the fiscal second quarter and six-month periods ended January 31, 2016.

PURE Bioscience Establishes Scientific Advisory Board To Leverage SDC-Based Antimicrobial Technologies To Ensure A Safer Food Supply

PURE Bioscience Establishes Scientific Advisory Board To Leverage SDC-Based Antimicrobial Technologies To Ensure A Safer Food Supply

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today announced that is has formed a Scientific Advisory Board and that it will be led by James L.

PURE Bioscience To Present At The 28th Annual ROTH Capital Partners Conference

PURE Bioscience To Present At The 28th Annual ROTH Capital Partners Conference

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the FDA approved, patented silver dihydrogen citrate ( SDC) antimicrobial, announced today the Company will present at the 28th Annual ROTH Capital Partners Conference...

PURE Bioscience Sets Q2 Results Conference Call To Review Progress Of FDA Approved PURE Control® Antimicrobial And The Company's Food Safety Solutions Strategy

PURE Bioscience Sets Q2 Results Conference Call To Review Progress Of FDA Approved PURE Control® Antimicrobial And The Company's Food Safety Solutions Strategy

PURE Bioscience, Inc. ( OTCQB: PURE), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, announced today that the Company will host an investor conference call on Wednesday, March 9, 2016 at 1:30pm PST...

PURE Bioscience Receives FDA Approval For Use Of SDC Antimicrobial As Poultry Processing Aid To Reduce Pathogens, Including Salmonella

PURE Bioscience Receives FDA Approval For Use Of SDC Antimicrobial As Poultry Processing Aid To Reduce Pathogens, Including Salmonella

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today announced that the FDA has completed its review of the safety and efficacy of the proposed use of...

PURE's SDC Antimicrobial Is A Featured Listeria Solution In Food Safety Consortium Presentation By James Marsden, Ph.D.

PURE's SDC Antimicrobial Is A Featured Listeria Solution In Food Safety Consortium Presentation By James Marsden, Ph.D.

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented silver dihydrogen citrate ( SDC) antimicrobial, today announced that the superior efficacy and safety of its SDC-based technology was highlighted as a...

PureCircle Wins Respected Sustainability Award

PureCircle Wins Respected Sustainability Award

Comprehensive impact on ecosystem, environment and public health

PURE Bioscience Reports 2013 Second Fiscal Quarter Financial Results

PURE Bioscience Reports 2013 Second Fiscal Quarter Financial Results

PURE Bioscience (NASDAQ: PURE ), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the second fiscal quarter ended January 31, 2013.

PURE Bioscience Appoints Dave Pfanzelter To Board Of Directors

PURE Bioscience Appoints Dave Pfanzelter To Board Of Directors

PURE Bioscience, Inc. (NASDAQ: PURE ), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that food industry leader Dave Pfanzelter has been appointed to the Board of Directors.

PURE Bioscience’s PURE Hard Surface Launched To Corporate And Government Customers Through Office Depot’s Business Solutions Division

PURE Bioscience’s PURE Hard Surface Launched To Corporate And Government Customers Through Office Depot’s Business Solutions Division

PURE Bioscience, Inc. (NASDAQ: PURE ), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that PURE Hard Surface disinfectant and food contact surface sanitizer is now available to...

PURE Protection: PURE Bioscience’s Hard Surface Disinfectant Provides Rapid 30-Second Kill Against Influenza

PURE Protection: PURE Bioscience’s Hard Surface Disinfectant Provides Rapid 30-Second Kill Against Influenza

PURE Bioscience, Inc. (NASDAQ: PURE ), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, is advising its institutional and household customers of the effectiveness of PURE™ Hard Surface...

PURE Bioscience Reports 2013 Fiscal First Quarter Financial Results

PURE Bioscience Reports 2013 Fiscal First Quarter Financial Results

PURE Bioscience (NASDAQ: PURE ), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2012.